The last three decades of cancer research were guided by the hypothesis that cancer cells
evolve due to the accumulation of many genetic aberrations over time. While this is still true …

Although the cure of acute leukaemia has improved significantly, many patients will still
relapse and die. The unraveling of the molecular pathogenesis of acute leukaemia has lead …

Medical management of myelodysplastic syndrome (MDS) remains challenging, particularly
in advanced stages where the risk of developing acute leukemia is very high and the …

目的介绍分子印迹技术及分子印迹聚合物, 综述分子印迹聚合物在各类给药系统中的应用.
方法对近几年发表的相关论文进行全面地回顾和整理, 阐述分子印迹聚合物在药物传递系统中的 …

Despite improvements to acute myelogenous leukemia (AML) therapy during the last 25
years, the majority of patients still succumb to the disease. Thus, there remains an urgent …

In the past 40 years, advances in supportive care and development of chemotherapeutic
agents have led to improved outcomes in patients with acute myeloid leukemia. High …

Lymphoid enhancer-binding factor 1 (LEF1) has been regarded as an important gene for
carcinogenesis in many malignancies, however, the role of LEF1 in the progression of …

A method for determining methylation density of target CpG islands has been established. In
the method, DNA microarray was prepared by spotting a set of PCR products amplified from …